HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats.

Abstract
A comparative study of the beta-receptor blockers propranolol, pindolol and carazolol, with respect to their cardio-protective properties against stress (hypoxia or isoprenaline injection) in rats showed the following. The beta-blockers investigated protected the heart against glycogen depletion during hypoxia. Carazolol was active at considerably lower doses than pindolol (about 25 times less) and propranolol (about 100 times later). All three beta-blockers protected against the induction of cardiac necroses by isoprenaline, but only carazolol produced almost complete protection. There is a good correlation between the protection against the development of cardiac necroses and the inhibition of tachycardia induced by isoprenaline (r = 0.96). The results are discussed from the point of view of the possible mechanisms by which the beta-blockers prevent cardiac damage induced by stress situations.
AuthorsW Bartsch, G Sponer, K Dietmann, M Kohler
JournalArzneimittel-Forschung (Arzneimittelforschung) Vol. 31 Issue 11 Pg. 1885-8 ( 1981) ISSN: 0004-4172 [Print] Germany
PMID6119093 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Propanolamines
  • carazolol
  • Glycogen
  • Propranolol
  • Pindolol
  • Isoproterenol
Topics
  • Adrenergic beta-Antagonists (pharmacology)
  • Animals
  • Coronary Disease (metabolism)
  • Glycogen (metabolism)
  • Heart Diseases (metabolism, prevention & control)
  • Isoproterenol (toxicity)
  • Membranes (drug effects)
  • Myocardium (metabolism)
  • Pindolol (pharmacology)
  • Propanolamines (pharmacology)
  • Propranolol (pharmacology)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: